| Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or-naive melanoma JS Weber, RR Kudchadkar, B Yu, D Gallenstein, CE Horak, HD Inzunza, ... Journal of clinical oncology 31 (34), 4311-4318, 2013 | 657 | 2013 |
| β-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer WM Clements, J Wang, A Sarnaik, OJ Kim, J MacDonald, ... Cancer research 62 (12), 3503-3506, 2002 | 457 | 2002 |
| HDAC inhibition upregulates PD-1 ligands in melanoma and augments immunotherapy with PD-1 blockade DM Woods, AL Sodré, A Villagra, A Sarnaik, EM Sotomayor, J Weber Cancer immunology research 3 (12), 1375-1385, 2015 | 418 | 2015 |
| Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer JI Youn, V Kumar, M Collazo, Y Nefedova, T Condamine, P Cheng, ... Nature immunology 14 (3), 211-220, 2013 | 380 | 2013 |
| Immunotherapy for gastrointestinal malignancies PG Toomey, NA Vohra, T Ghansah, AA Sarnaik, SA Pilon-Thomas Cancer Control 20 (1), 32-42, 2013 | 304 | 2013 |
| Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial BC Creelan, C Wang, JK Teer, EM Toloza, J Yao, S Kim, AM Landin, ... Nature medicine 27 (8), 1410-1418, 2021 | 237 | 2021 |
| Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit in patients with resected high-risk stage IIIc/IV melanoma AA Sarnaik, B Yu, D Yu, D Morelli, ML Hall, D Bogle, L Yan, S Targan, ... Clinical Cancer Research 17 (4), 896-906, 2011 | 218 | 2011 |
| Lifileucel, a tumor-infiltrating lymphocyte therapy, in metastatic melanoma AA Sarnaik, O Hamid, NI Khushalani, KD Lewis, T Medina, HM Kluger, ... Journal of Clinical Oncology 39 (24), 2656-2666, 2021 | 217 | 2021 |
| Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma S Pilon-Thomas, L Kuhn, S Ellwanger, W Janssen, E Royster, S Marzban, ... Journal of immunotherapy 35 (8), 615-620, 2012 | 204 | 2012 |
| The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms KHT Paraiso, HE Haarberg, E Wood, VW Rebecca, YA Chen, Y Xiang, ... Clinical cancer research 18 (9), 2502-2514, 2012 | 191 | 2012 |
| STIM1- and Orai1-mediated Ca2+ oscillation orchestrates invadopodium formation and melanoma invasion J Sun, F Lu, H He, J Shen, J Messina, R Mathew, D Wang, AA Sarnaik, ... Journal of Cell Biology 207 (4), 535-548, 2014 | 171 | 2014 |
| Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8+ melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy JA Chacon, RC Wu, P Sukhumalchandra, JJ Molldrem, A Sarnaik, ... PloS one 8 (4), e60031, 2013 | 163 | 2013 |
| Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors ML Hall, H Liu, M Malafa, B Centeno, PJ Hodul, J Pimiento, ... Journal for immunotherapy of cancer 4, 1-12, 2016 | 162 | 2016 |
| Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation KV Woan, M Lienlaf, P Perez-Villaroel, C Lee, F Cheng, T Knox, ... Molecular oncology 9 (7), 1447-1457, 2015 | 145 | 2015 |
| Essential role of HDAC6 in the regulation of PD-L1 in melanoma M Lienlaf, P Perez-Villarroel, T Knox, M Pabon, E Sahakian, J Powers, ... Molecular oncology 10 (5), 735-750, 2016 | 143 | 2016 |
| Biomarkers on melanoma patient T cells associated with ipilimumab treatment W Wang, D Yu, AA Sarnaik, B Yu, M Hall, D Morelli, Y Zhang, X Zhao, ... Journal of translational medicine 10, 1-12, 2012 | 138 | 2012 |
| Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma KN Kodumudi, A Weber, AA Sarnaik, S Pilon-Thomas The Journal of Immunology 189 (11), 5147-5154, 2012 | 135 | 2012 |
| The unique clinical characteristics of melanoma diagnosed in children D Han, JS Zager, G Han, SS Marzban, CA Puleo, AA Sarnaik, D Reed, ... Annals of surgical oncology 19, 3888-3895, 2012 | 92 | 2012 |
| Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma T Ghansah, N Vohra, K Kinney, A Weber, K Kodumudi, G Springett, ... Cancer Immunology, Immunotherapy 62, 1083-1091, 2013 | 91 | 2013 |
| Single-cell characterization of the immune microenvironment of melanoma brain and leptomeningeal metastases I Smalley, Z Chen, M Phadke, J Li, X Yu, C Wyatt, B Evernden, JL Messina, ... Clinical Cancer Research 27 (14), 4109-4125, 2021 | 90 | 2021 |
